These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 2839329)
21. Reversal of central benzodiazepine effects by flumazenil after conscious sedation produced by intravenous diazepam. The Flumazenil in Intravenous Conscious Sedation with Diazepam Multicenter Study Group I. Clin Ther; 1992; 14(6):895-909. PubMed ID: 1286497 [TBL] [Abstract][Full Text] [Related]
22. The effect of benzodiazepine receptor antagonism by flumazenil on the MAC of halothane in the rat. Greiner AS; Larach DR Anesthesiology; 1989 Apr; 70(4):644-8. PubMed ID: 2539028 [TBL] [Abstract][Full Text] [Related]
23. The role of flumazenil in the critically ill. Park GR; Navapurkar V; Ferenci P Acta Anaesthesiol Scand Suppl; 1995; 108():23-34. PubMed ID: 8693921 [TBL] [Abstract][Full Text] [Related]
24. Clinical experience with the benzodiazepine antagonist flumazenil in suspected benzodiazepine or ethanol poisoning. Martens F; Köppel C; Ibe K; Wagemann A; Tenczer J J Toxicol Clin Toxicol; 1990; 28(3):341-56. PubMed ID: 2231833 [TBL] [Abstract][Full Text] [Related]
25. [Clinical pharmacology of flumazenil--a benzodiazepine receptor antagonist]. Janicki P; Rewerski W Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1653-6. PubMed ID: 2855862 [No Abstract] [Full Text] [Related]
26. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt. Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303 [TBL] [Abstract][Full Text] [Related]
28. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt. Savić MM; Obradović DI; Ugresić ND; Cook JM; Sarma PV; Bokonjić DR Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222 [TBL] [Abstract][Full Text] [Related]
29. Effect of intravenous flumazenil on reversal of the central effects of midazolam used with short-acting opioids for general anesthesia in hospitalized patients: report of a multicenter, double-blind clinical study. The Flumazenil in General Anesthesia in Hospitalized Patients Study Group I. Clin Ther; 1992; 14(6):924-38. PubMed ID: 1286499 [TBL] [Abstract][Full Text] [Related]
30. Assessment of benzodiazepine receptor heterogeneity in vivo: apparent pA2 and pKB analyses from behavioral studies. Rowlett JK; Woolverton WL Psychopharmacology (Berl); 1996 Nov; 128(1):1-16. PubMed ID: 8944400 [TBL] [Abstract][Full Text] [Related]
32. Topics in clinical pharmacology: flumazenil, a benzodiazepine antagonist. Longmire AW; Seger DL Am J Med Sci; 1993 Jul; 306(1):49-52. PubMed ID: 8101045 [TBL] [Abstract][Full Text] [Related]
33. Effects of diazepam and flumazenil on forebrain ischaemia in a rat model of benzodiazepine tolerance. Iwata M; Inoue S; Kawaguchi M; Furuya H Br J Anaesth; 2012 Dec; 109(6):935-42. PubMed ID: 23043146 [TBL] [Abstract][Full Text] [Related]
34. [Benzodiazepine antagonists in the treatment of heptic encephalopathy]. Ferenci P; Grimm G Leber Magen Darm; 1989 Dec; 19(6):322-5. PubMed ID: 2575692 [TBL] [Abstract][Full Text] [Related]
35. Endogenous ligands of benzodiazepine binding site have inverse agonistic properties. Sliva J; Hess L; Votava M; Malek J Med Hypotheses; 2013 Dec; 81(6):1075-7. PubMed ID: 24183322 [TBL] [Abstract][Full Text] [Related]
36. [Ethanol intoxication treated with flumazenil: a case report]. Hung DZ; Huang FJ; Deng JF; Tsai WJ Zhonghua Yi Xue Za Zhi (Taipei); 1991 Dec; 48(6):485-8. PubMed ID: 1664290 [TBL] [Abstract][Full Text] [Related]
37. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil. Mandema JW; Tukker E; Danhof M J Pharmacol Exp Ther; 1992 Jan; 260(1):36-44. PubMed ID: 1309878 [TBL] [Abstract][Full Text] [Related]
38. The benzodiazepine receptor antagonist, flumazenil does not block clinical effects of delta-9-tetrahydrocannabinol. Hollister LE; Gillespie HK Life Sci; 1990; 47(18):1655-60. PubMed ID: 2174492 [TBL] [Abstract][Full Text] [Related]